Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsNKT cell subsets as key participants in liver physiology and pathologyAntitumor Responses of Invariant Natural Killer T CellsImmunology of hepatocellular carcinomaThe regulatory role of invariant NKT cells in tumor immunityΑ-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsFibrosis-dependent mechanisms of hepatocarcinogenesisLipid antigens in immunity.Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cellsImmunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.Percentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment.Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.The split personality of NKT cells in malignancy, autoimmune and allergic disordersNKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansCD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responsesLiver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.Tumor microenviroment and hepatocellular carcinoma metastasis.Natural killer T cells in liver injury, inflammation and cancer.Regulation of NKT Cell Localization in Homeostasis and InfectionChimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy.Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infectionIsolation and Functional Use of Human NKT Cells.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancerThe Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in TissuesThe Role of CD1d and MR1 Restricted T Cells in the Liver
P2860
Q21284987-D60AD4A8-4346-4A84-B287-1F12C88F4D6AQ26766141-11A409AB-C237-4307-9E93-592727E08814Q26778648-C31C9852-8DDD-479D-8D97-792E83F737A3Q26795411-9A1F674D-BE02-4739-9B53-971A896A773AQ27023425-DB78BC2F-F694-42D3-BB8F-315FDE8FD848Q33778356-CB9AEC62-9C22-47FF-A522-6A5BE14B6D17Q33865082-BEC862CC-1D69-4F62-9B24-DAF6D0FCC348Q34025822-3B6B9AA6-D270-40A2-A5EE-84320F580967Q34083483-4A66204E-8186-4AF1-96DB-DC3D186C72E3Q34103244-30897518-5950-4EEF-BEE0-8ABDBAA73035Q34187221-DB9CBDAC-1B51-4BBF-AB78-08F34A7BF718Q34821857-2368C1B1-0AC0-4896-B1E2-7AA56FEF602FQ34934974-6886A6A7-8891-4334-9F09-BA2C8EFCC8E6Q35127172-9C0406F6-7EEB-4EDD-ABF7-5CB4F2C1EFCBQ35590727-C623BEA4-A207-45BF-9F4F-4A21C4E44021Q35956535-74F70A57-D023-4477-988D-47E6B08B3D6BQ36239694-72A4AA43-2F22-4F5D-B1A8-F61BF7975578Q36759287-1DA2A9E4-CE47-4C64-BB38-1038449A3893Q37326768-21D089E9-0E84-4537-BA55-1A6736573431Q37381691-457AE50D-EC5B-49E6-8B19-BB32AC48336BQ37945304-FB7BC32F-1A7C-43B6-9952-CF0B9739F251Q38121570-E858FA7B-CDB9-4588-B514-9847B40CB3F3Q38525797-0D91A7AC-F663-4A4F-8D02-088D2FE0FDAEQ38527820-F196CCBD-654C-4039-94E8-2D5B5D74290FQ38666579-82E9AA32-1059-45B1-BB9A-479E198346CBQ39104455-6C56A760-481F-45AA-82D7-4E76417920C9Q39297216-22750D04-7CE0-40DE-A931-48CFF767FA7AQ39644938-A4025EF8-101A-4AAD-860C-3E99991BF8B6Q42258972-2BB25188-7395-4B58-AC4C-F19BE9552DB4Q47578808-C084A510-9787-45B5-9D77-1301582C81AAQ55094012-26C22870-467D-4170-B112-67F386FBF2A7Q57807125-87A109A8-C46E-46B9-9790-B72F9E36FECCQ58122550-9274732B-FC64-47C1-8535-B8F638D80584Q58697988-95E44C95-108D-4259-95DE-993A7CB19ED4
P2860
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Enrichment of human CD4+ V
@nl
Enrichment of human CD4+ V(alp ...... intrahepatic malignant tumors.
@en
type
label
Enrichment of human CD4+ V
@nl
Enrichment of human CD4+ V(alp ...... intrahepatic malignant tumors.
@en
prefLabel
Enrichment of human CD4+ V
@nl
Enrichment of human CD4+ V(alp ...... intrahepatic malignant tumors.
@en
P2093
P356
P1476
Enrichment of human CD4+ V(alp ...... intrahepatic malignant tumors.
@en
P2093
Catherine Barbey
Daniel E Speiser
Estelle Devevre
Gabriel Bricard
H Robson Macdonald
Hanifa Bouzourene
Jean-Charles Cerottini
Nathalie Rufer
Olivier Martinet
P304
P356
10.4049/JIMMUNOL.0711086
P407
P577
2009-04-01T00:00:00Z